Back
EyePoint Pharmaceuticals Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
56
EYPT
EyePoint Pharmaceuticals
Last Price:
12.05
Seasonality Move:
19.48%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.47 | Buy |
| 20-day SMA: | 10.45 | Buy |
| 50-day SMA: | 9.29 | Buy |
| 200-day SMA: | 14.61 | Sell |
| 8-day EMA: | 11.42 | Buy |
| 20-day EMA: | 10.64 | Buy |
| 50-day EMA: | 9.83 | Buy |
| 200-day EMA: | 11.64 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | 288172 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.64 - 11.44) | Buy |
| Bollinger Bands (100): | (8.05 - 10.13) | Buy |
EyePoint Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 11.61 while EYPT 8-day simple moving average is 11.47, which is a Buy signal.
- The stock price of EYPT is 11.61 while EyePoint Pharmaceuticals 20-day SMA is 10.45, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day simple moving average is 9.29 while EYPT share price is 11.61, making it a Buy technically.
- EYPT stock price is 11.61 and EyePoint Pharmaceuticals 200-day simple moving average is 14.61, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
56
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $11.61. The Score for EYPT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
621.35M
Price in USD:
11.61
Share Volume:
416.25K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.86
Buy
56
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 11.61 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 11.61 while EYPT 8-day exponential moving average is 11.42, which is a Buy signal.
- The stock price of EYPT is 11.61 while EyePoint Pharmaceuticals 20-day EMA is 10.64, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.83 while EYPT share price is 11.61, making it a Buy technically.
- EYPT stock price is 11.61 and EyePoint Pharmaceuticals 200-day simple moving average is 11.64, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.83 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is 0.78, suggesting EyePoint Pharmaceuticals is a Buy
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 61.26, which suggest EyePoint Pharmaceuticals is overbought
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.64 - 11.44), which suggest EyePoint Pharmaceuticals is a Buy
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (8.05 - 10.13), which suggest EyePoint Pharmaceuticals is a Buy
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.